Effects of Bifidobacterium longum subsp. longum CCFM1113 and Bifidobacterium adolescentis CCFM1386 compound probiotics on metabolism and gut microbiota in prediabetes mice

  • LI Liuruolan ,
  • ZHAO Yurong ,
  • WANG Yi ,
  • YU Xihua ,
  • LU Wenwei ,
  • WANG Hongchao ,
  • WU Wenjun
Expand
  • 1(Sinopharm Xingsha Pharmaceutical (Xiamen) Co.Ltd., Xiamen 361026, China)
    2(Xiamen Key Laboratory of Maternal and Infant Health and Nutrition Products, Xiamen 361026, China)
    3(School of Food Science and Technology, Jiangnan University, Wuxi 214122, China)
    4(Jinshan Branch of Shanghai Sixth People’s Hospital, Shanghai 201599, China)

Received date: 2025-07-31

  Revised date: 2025-09-09

  Online published: 2026-06-24

Abstract

Prediabetes is a chronic metabolic disease with high prevalence and may develop into type II diabetes.Thus, safe and effective early intervention strategies are urgently needed.Probiotics have great potential in improving glucose metabolism, but the specific effects and potential mechanisms of compound probiotics in prediabetes remain to be further explored.Therefore, in this study, Bifidobacterium longum subsp. longum CCFM1113 and Bifidobacterium adolescentis CCFM1386 were compounded to study their effects on prediabetes mice induced by high-fat diet combined with streptozotocin (STZ).The results showed that compared with the model group, the compound probiotics significantly reduced weight gain, improved glucose tolerance, modulate glucose metabolism, and reduced insulin resistance;In addition, through histopathological analysis, it was found that the compound probiotics had protective effects on the liver and pancreas of prediabetes mice, and also significantly reduced the contents of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in the liver of mice.Metagenomic sequencing of gut microbiota showed that the compound probiotics can increase microbiota diversity and help restore microbiota structure, promoting the growth of beneficial bacterial related to the regulation of metabolic disorders.The above results indicate that the compound probiotics can alleviate the symptoms of prediabetes mice by regulating metabolism and promoting the growth of beneficial bacteria.

Cite this article

LI Liuruolan , ZHAO Yurong , WANG Yi , YU Xihua , LU Wenwei , WANG Hongchao , WU Wenjun . Effects of Bifidobacterium longum subsp. longum CCFM1113 and Bifidobacterium adolescentis CCFM1386 compound probiotics on metabolism and gut microbiota in prediabetes mice[J]. Food and Fermentation Industries, 2026 , 52(11) : 45 -52 . DOI: 10.13995/j.cnki.11-1802/ts.044104

References

[1] LI Y, WU Y, WU L L, et al.The effects of probiotic administration on patients with prediabetes:A meta-analysis and systematic review[J].Journal of Translational Medicine, 2022, 20(1):498.
[2] GALICIA-GARCIA U, BENITO-VICENTE A, JEBARI S, et al.Pathophysiology of type 2 diabetes mellitus[J].International Journal of Molecular Sciences, 2020, 21(17):6275.
[3] LIU H D, XING Y, WANG Y B, et al.Dendrobium officinale polysaccharide prevents diabetes via the regulation of gut microbiota in prediabetic mice[J].Foods, 2023, 12(12):2310.
[4] KHETAN A K, RAJAGOPALAN S.Prediabetes[J].Canadian Journal of Cardiology, 2018, 34(5):615-623.
[5] SÁNCHEZ B, DELGADO S, BLANCO-MÍGUEZ A, et al.Probiotics, gut microbiota, and their influence on host health and disease[J].Molecular Nutrition & Food Research, 2017, 61(1).DOI:10.1002/mnfr.201600240.
[6] LUC K, SCHRAMM-LUC A, GUZIK T J, et al.Oxidative stress and inflammatory markers in prediabetes and diabetes[J].Journal of Physiology and Pharmacology, 2019, 70(6).DOI:10.26402/jpp.2019.6.01.
[7] MOHAMADSHAHI M, VEISSI M, HAIDARI F, et al.Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes[J].BioImpacts, 2014, 4(2):83-88.
[8] NAITO E, YOSHIDA Y, KUNIHIRO S, et al.Effect of Lactobacillus casei strain Shirota-fermented milk on metabolic abnormalities in obese prediabetic Japanese men:A randomised, double-blind, placebo-controlled trial[J].Bioscience of Microbiota, Food and Health, 2018, 37(1):9-18.
[9] SCHELLEKENS H, TORRES-FUENTES C, VAN DE WOUW M, et al.Bifidobacterium longum counters the effects of obesity:Partial successful translation from rodent to human[J].EBioMedicine, 2021, 63:103176.
[10] QIAN X, SI Q, LIN G P, et al.Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity[J].Nutrients, 2022, 14(12):2479.
[11] CHEN Y, SHEN X, MA T, et al.Adjunctive probio-X treatment enhances the therapeutic effect of a conventional drug in managing type 2 diabetes mellitus by promoting short-chain fatty acid-producing bacteria and bile acid pathways[J].mSystems, 2023, 8(1):e01300-e01322.
[12] WANG H C, SONG W Y, YUAN W W, et al.Modulating the human gut microbiota through hypocaloric balanced diets:An effective approach for managing obesity[J].Nutrients, 2023, 15(14):3101.
[13] 王丽, 周志谟, 卿烈铭, 等.长双歧杆菌婴儿亚种B79介导巨噬细胞对前脂肪细胞成脂分化和脂质代谢的调节作用[J].食品研究与开发, 2025, 46(18):53-61.
WANG L, ZHOU Z M, QING L M, et al.Macrophage-mediated regulatory effects of Bifidobacterium longum subsp.infantis B79 on adipogenesis and lipid metabolism of preadipocytes[J].Food Research and Development, 2025, 46(18):53-61.
[14] 潘子怡, 陈则华, 毛丙永, 等.青春双歧杆菌冻干保护剂筛选及高密度冻干工艺优化[J].食品与生物技术学报, 2024, 43(2):23-29.
PAN Z Y, CHEN Z H, MAO B Y, et al.Screening of lyoprotectants and optimization of high-density freeze-drying process for Bifidobacterium adolescentis[J].Journal of Food Science and Biotechnology, 2024, 43(2):23-29.
[15] WANG K L, KONG L H, WEN X, et al.The positive effect of 6-gingerol on high-fat diet and streptozotocin-induced prediabetic mice:Potential pathways and underlying mechanisms[J].Nutrients, 2023, 15(4):824.
[16] 陈峰, 马微微, 于雷雷, 等.植物乳杆菌CCFM8661增强小鼠免疫力的功能评价[J].食品与生物技术学报, 2024, 43(5):37-43.
CHEN F, MA W W, YU L L, et al.Functional evaluation of lactiplantibacillus plantarum CCFM8661 for enhancing immunity in mice[J].Journal of Food Science and Biotechnology, 2024, 43(5):37-43.
[17] WANG H C, CHEN Y T, FENG L, et al.A gut aging clock using microbiome multi-view profiles is associated with health and frail risk[J].Gut Microbes, 2024, 16(1):2297852.
[18] BI Y R, YANG Y, YUAN X J, et al.Association between liver enzymes and type 2 diabetes:A real-world study[J].Frontiers in Endocrinology, 2024, 15:1340604.
[19] WORETA T A, ALQAHTANI S A.Evaluation of abnormal liver tests[J].The Medical Clinics of North America, 2014, 98(1):1-16.
[20] BLANDINO G, INTURRI R, LAZZARA F, et al.Impact of gut microbiota on diabetes mellitus[J].Diabetes & Metabolism, 2016, 42(5):303-315.
[21] LIU S, QIN P P, WANG J.High-fat diet alters the intestinal microbiota in streptozotocin-induced type 2 diabetic mice[J].Microorganisms, 2019, 7(6):176.
[22] LE GALL M, THENET S, AGUANNO D, et al.Intestinal plasticity in response to nutrition and gastrointestinal surgery[J].Nutrition Reviews, 2019, 77(3):129-143.
[23] YANG M, WANG J H, SHIN J H, et al.Pharmaceutical efficacy of novel human-origin Faecalibacterium prausnitzii strains on high-fat-diet-induced obesity and associated metabolic disorders in mice[J].Frontiers in Endocrinology, 2023, 14:1220044.
[24] PETERSEN M C, SHULMAN G I.Mechanisms of insulin action and insulin resistance[J].Physiological Reviews, 2018, 98(4):2133-2223.
[25] 陈兆斌, 黄丽媛, 王炳元, 等.代谢相关脂肪性肝病与2型糖尿病的关系及共病机制研究进展[J].临床肝胆病杂志, 2023, 39(10):2454-2459.
CHEN Z B, HUANG L Y, WANG B Y, et al.Research advances in the association between metabolic associated fatty liver and type 2 diabetes mellitus and the mechanism of comorbidity[J].Journal of Clinical Hepatology, 2023, 39(10):2454-2459.
[26] MOHAMED J, NAZRATUN NAFIZAH A H, ZARIYANTEY A H, et al.Mechanisms of diabetes-induced liver damage:The role of oxidative stress and inflammation[J].Sultan Qaboos University Medical Journal, 2016, 16(2):e132-e141.
[27] GREEN R M, FLAMM S.AGA technical review on the evaluation of liver chemistry tests[J].Gastroenterology, 2002, 123(4):1367-1384.
[28] ZHU X X, ZHAO C Y, MENG X Y, et al.Bacteroides uniformis ameliorates carbohydrate and lipid metabolism disorders in diabetic mice by regulating bile acid metabolism via the gut-liver axis[J].Pharmaceuticals, 2024, 17(8):1015.
[29] SHE J Q, TUERHONGJIANG G, GUO M Y, et al.Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner[J].Cell Metabolism, 2024, 36(2):408-421.e5.
Outlines

/

〈 〉